FR2972355B3 - ANTIMICROBIAL MIXTURE AND COATING TO ASSIST WITH HEALING, HAVING ANTIMICROBIAL EFFECT - Google Patents

ANTIMICROBIAL MIXTURE AND COATING TO ASSIST WITH HEALING, HAVING ANTIMICROBIAL EFFECT

Info

Publication number
FR2972355B3
FR2972355B3 FR1252163A FR1252163A FR2972355B3 FR 2972355 B3 FR2972355 B3 FR 2972355B3 FR 1252163 A FR1252163 A FR 1252163A FR 1252163 A FR1252163 A FR 1252163A FR 2972355 B3 FR2972355 B3 FR 2972355B3
Authority
FR
France
Prior art keywords
antimicrobial
healing
mixture
assist
coating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR1252163A
Other languages
French (fr)
Other versions
FR2972355A3 (en
Inventor
Zuzana Valentova
Sarka Duskova
Michal Zavadil
Veronika Hekrlova
Vladimir Velebny
Lubos Sobotka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Contipro AS
Original Assignee
Contipro Pharma AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Contipro Pharma AS filed Critical Contipro Pharma AS
Publication of FR2972355A3 publication Critical patent/FR2972355A3/en
Application granted granted Critical
Publication of FR2972355B3 publication Critical patent/FR2972355B3/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/225—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
    • A61L2300/206—Biguanides, e.g. chlorohexidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
    • A61L2300/208—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to an antimicrobial mixture for healing of superficial wounds based on a physiologically acceptable hyaluronic acid salt, optionally with one or more other polysaccharides, and a compound having an antimicrobial activity, which can be used for healing of superficial wounds, especially chronic wounds, for example varicose ulcers, and to a covering which contains said mixture.
FR1252163A 2011-03-11 2012-03-09 ANTIMICROBIAL MIXTURE AND COATING TO ASSIST WITH HEALING, HAVING ANTIMICROBIAL EFFECT Expired - Lifetime FR2972355B3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CZ201124045U CZ22394U1 (en) 2011-03-11 2011-03-11 Antimicrobial mixture and cover to support healing of wounds with antimicrobial effect

Publications (2)

Publication Number Publication Date
FR2972355A3 FR2972355A3 (en) 2012-09-14
FR2972355B3 true FR2972355B3 (en) 2013-03-22

Family

ID=44189522

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1252163A Expired - Lifetime FR2972355B3 (en) 2011-03-11 2012-03-09 ANTIMICROBIAL MIXTURE AND COATING TO ASSIST WITH HEALING, HAVING ANTIMICROBIAL EFFECT

Country Status (12)

Country Link
JP (1) JP3196712U (en)
AR (1) AR088721A4 (en)
AT (1) AT13850U1 (en)
BR (1) BR112013023201A2 (en)
CZ (1) CZ22394U1 (en)
DE (1) DE212012000057U1 (en)
DK (1) DK201300152Y3 (en)
FR (1) FR2972355B3 (en)
HU (1) HU4499U (en)
IT (1) ITMI20120370A1 (en)
RU (1) RU149063U1 (en)
WO (1) WO2012122956A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITBO20120185A1 (en) * 2012-04-06 2013-10-07 Emodial S R L ANTIMICROBIAL MEDICATION, ANTIMICROBIAL COMPOSITION AND ITS USE
CZ28634U1 (en) * 2015-05-05 2015-09-14 Contipro Pharma A.S. Hyaluronan and octenidine dihydrochloride-based dental composition
DE102016007892A1 (en) * 2016-06-21 2017-12-21 Nejmo Harb The reactive and protective plaster
WO2018021326A1 (en) 2016-07-27 2018-02-01 株式会社リタファーマ Oral mucosa application material and method for producing same
DE102016009877A1 (en) * 2016-08-08 2018-02-08 Nejmo Harb Reaction protective patch
CN106178069A (en) * 2016-08-30 2016-12-07 苏州美迪斯医疗运动用品股份有限公司 A kind of first aid bleeding-stopping dressing and preparation method thereof
JP6839477B2 (en) * 2017-01-30 2021-03-10 多木化学株式会社 Collagen structure
CZ307615B6 (en) * 2017-06-05 2019-01-16 Contipro A.S. An antimicrobial composition comprising a polysaccharide, a stabilizer and a triiodide, a method for its preparation and use
CZ2018428A3 (en) 2018-08-23 2019-12-04 Contipro As A composition containing an iodide and a derivative of hyaluronic acid with an oxidizing effect, process of preparing it and use
CN110652609A (en) * 2019-07-31 2020-01-07 武汉理工大学 Alginate dressing loaded with silver-zinc micro-battery and preparation method thereof
CN111939306A (en) * 2020-08-21 2020-11-17 江苏诺瓦立医疗用品有限公司 Antibacterial dressing and application thereof
US20210378870A1 (en) * 2020-08-24 2021-12-09 University Of Utah Research Foundation Multi-functional analgesic-releasing wound dressing

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1229075B (en) 1985-04-05 1991-07-17 Fidia Farmaceutici Topical compsn. contg. hyaluronic acid deriv. as vehicle
US5128136A (en) 1990-07-16 1992-07-07 The Oregon Health Sciences University Wound healing kit comprised of gelable collagen
US7691829B2 (en) * 1998-03-24 2010-04-06 Petito George D Composition and method for healing tissues
DE102005017845A1 (en) * 2005-04-18 2006-10-19 Lohmann & Rauscher Gmbh & Co. Kg Autosterile, antiseptic collagen preparations, their use and methods of preparation
ITMI20051569A1 (en) * 2005-08-11 2007-02-12 Biokosmes S R L CICATRIZING COMPOSITION
US20070264226A1 (en) * 2006-05-10 2007-11-15 Karagoezian Hampar L Synergistically enhanced disinfecting solutions
CZ303471B6 (en) * 2007-10-03 2012-10-03 Contipro Biotech S.R.O. Composition containing chitosan-glucan intended for healing wounds and preventing adhesion of bandage to wound
US20100055158A1 (en) * 2008-08-28 2010-03-04 Tyco Healthcare Group Lp Environmentally Activated Compositions, Articles and Methods
WO2010025219A1 (en) * 2008-08-28 2010-03-04 Tyco Healthcare Group Lp Antimicrobial foam compositions, articles and methods
DE102009049504A1 (en) * 2009-10-15 2011-04-21 Schülke & Mayr GmbH Wound and mucous membrane antiseptic based on bispyridiniumalkanes

Also Published As

Publication number Publication date
BR112013023201A2 (en) 2016-09-20
RU149063U1 (en) 2014-12-20
DK201300152U1 (en) 2013-10-25
DE212012000057U1 (en) 2013-09-26
AR088721A4 (en) 2014-07-02
CZ22394U1 (en) 2011-06-20
AT13850U1 (en) 2014-10-15
DK201300152Y3 (en) 2014-02-14
FR2972355A3 (en) 2012-09-14
HU4499U (en) 2015-01-28
JP3196712U (en) 2015-04-02
ITMI20120370A1 (en) 2012-09-12
WO2012122956A1 (en) 2012-09-20

Similar Documents

Publication Publication Date Title
FR2972355B3 (en) ANTIMICROBIAL MIXTURE AND COATING TO ASSIST WITH HEALING, HAVING ANTIMICROBIAL EFFECT
MX2015016100A (en) Cryopyrin inhibitors for preventing and treating inflammation.
EA201400119A1 (en) PHARMACEUTICAL COMPOSITION, METHODS OF TREATMENT AND THEIR APPLICATION
WO2011140310A3 (en) Povidone-iodine topical composition
MX2015003239A (en) Topical compositions and methods of use.
BR112015030543B8 (en) Preparation for topical application for the treatment of skin and mucosal infections
BR112013020159A2 (en) method to inhibit hamartoma tumor cells
GT201200345A (en) HETEROCYCLIC COMPOUNDS, THEIR PREPARATION AND THEIR THERAPY APPLICATION
EA201200786A1 (en) COMBINED COMPOSITION CONTAINING AS AN ACTIVE INGREDIENT L-CARNITIN OR PROPIONIL-L-CARNITIN FOR THE PREVENTION OR TREATMENT OF CHRONIC VENOUS INSUFFICIENCY
AU2011322715A8 (en) Treatment of MeCP2-associated disorders
FR2978665B1 (en) ANTISEPTIC COMPOSITION
BR112015022825A2 (en) methods of diagnosis, selection and treatment of diseases and conditions caused by or associated with methanogens
CO6680624A2 (en) Keloid Treatment
WO2014152437A3 (en) Methods of use for an antimicrobial peptide
WO2014145236A3 (en) The use of sdf-1 to mitigate scar formation
EA201001254A1 (en) COMPOSITION FOR DOWNLOADING REGULATION OF CONSCIOUSNESS MARKERS
WO2014078446A3 (en) Skin wound healing and scar reduction with prostaglandin ep4 agonist combinations
WO2014070696A3 (en) Treatment of chronic dermal inflammatory with norketotifen
WO2013140119A3 (en) Pre-harvest treatment
PH12015501210A1 (en) Use of pidotimod to treat psoriasis
JP2017513945A5 (en)
AU2018258588A8 (en) Inhibitors of TRIM33 and methods of use
WO2014009315A3 (en) Use of zinc coceth sulfate as an antibacterial agent against propionibacterium acnes
MX2023005014A (en) Methods of treating chronic inflammatory diseases.
BR112016006426A2 (en) method of treating atrophic skin scars

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

CD Change of name or company name

Owner name: CONTIPRO A.S., CZ

Effective date: 20170113